A macromolecular approach to eradicate multidrug resistant bacterial infections while mitigating drug resistance onset

Willy Chin(Institute of Bioengineering and Nanotechnology), Yi Yan Yang(Institute of Bioengineering and Nanotechnology)

Nature Communications

February 26, 2018

10.1038/s41467-018-03325-6

Cited by 330

Related Papers

Evaluating the lifetime cumulative dose as a basis for carcinogenic potency of nitrosamines – a key tenet underpinning less-than-lifetime approaches for establishing acceptable intake limits

|Regulatory Toxicology and Pharmacology|2025|5

Opportunities for More Tailored Approaches to Genotoxicity Testing and Carcinogenicity Strategy for Oligonucleotide Therapeutics: Outcome of an Industry Survey

|Nucleic Acid Therapeutics|2025|2